AbbVie
ABBV
#29
Rank
S$475.58 B
Marketcap
S$268.97
Share price
1.11%
Change (1 day)
1.78%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : S$176.15 Billion

According to AbbVie's latest financial reports the company's total liabilities are S$176.15 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$176.13 B-1.68%
2024-12-31S$179.14 B9.12%
2023-12-31S$164.18 B0.78%
2022-12-31S$162.90 B-8.08%
2021-12-31S$177.22 B-2.55%
2020-12-31S$181.86 B38.66%
2019-12-31S$131.16 B41.61%
2018-12-31S$92.62 B5.42%
2017-12-31S$87.85 B-1.23%
2016-12-31S$88.95 B28.07%
2015-12-31S$69.46 B103.98%
2014-12-31S$34.05 B8.79%
2013-12-31S$31.30 B8.25%
2012-12-31S$28.91 B194.21%
2011-12-31S$9.82 B40.47%
2010-12-31S$6.99 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
S$155.86 B-11.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$110.35 B-37.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$105.19 B-40.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.35 B-91.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$46.74 B-73.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$91.85 B-47.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$83.91 B-52.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$78.09 B-55.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.76 B-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA